Molecular Characteristics of Rifampin-Sensitive and -Resistant Isolates and Characteristics of rpoB Gene Mutations in Methicillin-Resistant Staphylococcus aureus

References

• Gould IM. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control. Int J Antimicrob Agents. 2006;28:379–384. doi:10.1016/j.ijantimicag.2006.09.00117045462
   PubMed Web of Science ®Google Scholar
• Gajdacs M, Urban E. Epidemiology and resistance trends of Staphylococcus aureus isolated from vaginal samples: a 10-year retrospective study in Hungary. Acta Dermatovenerol Alp Pannonica Adriat. 2019;28:143–147.31855266
   PubMed Web of Science ®Google Scholar
• Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520–532. doi:10.1056/NEJM1998082033908069709046
   PubMed Web of Science ®Google Scholar
• Turner NA, Sharma-Kuinkel BK, Maskarinec SA, et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol. 2019;17:203–218. doi:10.1038/s41579-018-0147-430737488
   PubMed Web of Science ®Google Scholar
• Lakhundi S, Zhang K. Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology. Clin Microbiol Rev. 2018;31. doi:10.1128/CMR.00020-18.
   Web of Science ®Google Scholar
• Liu Y, Wang H, Du N, et al. Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals. Antimicrob Agents Chemother. 2009;53:512–518. doi:10.1128/AAC.00804-0819029328
   PubMed Web of Science ®Google Scholar
• Dai Y, Liu J, Guo W, et al. Decreasing methicillin-resistant Staphylococcus aureus (MRSA) infections is attributable to the disappearance of predominant MRSA ST239 clones, Shanghai, 2008–2017. Emerg Microbes Infect. 2019;8:471–478. doi:10.1080/22221751.2019.159516130924398
   PubMed Web of Science ®Google Scholar
• Mick V, Domínguez MA, Tubau F, et al. Molecular characterization of resistance to rifampicin in an emerging hospital-associated methicillin-resistant Staphylococcus aureus clone ST228, Spain. BMC Microbiol. 2010;10:68. doi:10.1186/1471-2180-10-6820202188
   PubMed Web of Science ®Google Scholar
• Gajdacs M. The continuing threat of methicillin-resistant Staphylococcus aureus. Antibiotics (Basel). 2019;8. doi:10.3390/antibiotics8020052.
   Web of Science ®Google Scholar
• Koreen L, Ramaswamy SV, Graviss EA, et al. spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J Clin Microbiol. 2004;42:792–799. doi:10.1128/JCM.42.2.792-799.200414766855
   PubMed Web of Science ®Google Scholar
• Walsh C. Deconstructing vancomycin. Science. 1999;284:442–443. doi:10.1126/science.284.5413.44210232990
   PubMed Web of Science ®Google Scholar
• Graziani AL, Lawson LA, Gibson GA, Steinberg MA, MacGregor RR. Vancomycin concentrations in infected and noninfected human bone. Antimicrob Agents Chemother. 1988;32:1320–1322. doi:10.1128/AAC.32.9.13203195994
   PubMed Web of Science ®Google Scholar
• Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev. 2010;23:99–139. doi:10.1128/CMR.00042-0920065327
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Cui L, Katayama Y, Kozue K, Hiramatsu K. Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus. J Clin Microbiol. 2011;49:2680–2684. doi:10.1128/JCM.02144-1021525224
   PubMed Web of Science ®Google Scholar
• Cui L, Isii T, Fukuda M, et al. An rpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus. Antimicrob Agents Chemother. 2010;54:5222–5233. doi:10.1128/AAC.00437-1020837752
   PubMed Web of Science ®Google Scholar
• Aiba Y, Katayama Y, Hishinuma T, et al. Mutation of RNA polymerase beta-subunit gene promotes heterogeneous-to-homogeneous conversion of beta-lactam resistance in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2013;57:4861–4871. doi:10.1128/AAC.00720-1323877693
   PubMed Web of Science ®Google Scholar
• Matsuo M, Hishinuma T, Katayama Y, et al. Mutation of RNA polymerase β subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3. Antimicrob Agents Chemother. 2011;55:4188–4195. doi:10.1128/AAC.00398-1121746940
   PubMed Web of Science ®Google Scholar
• Guerillot R, Gonçalves da Silva A, Monk I, et al. Convergent evolution driven by rifampin exacerbates the global burden of drug-resistant Staphylococcus aureus. mSphere. 2018;3. doi:10.1128/mSphere.00550-17
   Web of Science ®Google Scholar
• Aboshkiwa M, Rowland G, Coleman G. Nucleotide sequence of the Staphylococcus aureus RNA polymerase rpoB gene and comparison of its predicted amino acid sequence with those of other bacteria. Biochim Biophys Acta. 1995;1262:73–78. doi:10.1016/0167-4781(95)00054-k7772603
   PubMed Web of Science ®Google Scholar
• Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 1998;279:1537–1541. doi:10.1001/jama.279.19.15379605897
   PubMed Web of Science ®Google Scholar
• Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:e1–e25. doi:10.1093/cid/cis80323223583
   PubMed Web of Science ®Google Scholar
• Senobar Tahaei SA, Stájer A, Barrak I, et al. Correlation between biofilm-formation and the antibiotic resistant phenotype in Staphylococcus aureus isolates: a laboratory-based study in Hungary and a review of the literature. Infect Drug Resist. 2021;14:1155–1168. doi:10.2147/IDR.S30399233790586
   PubMed Web of Science ®Google Scholar
• Ju O, Woolley M, Gordon D. Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin-rifampicin combination therapy in an intensive care unit. Eur J Clin Microbiol Infect Dis. 2006;25:61–62. doi:10.1007/s10096-005-0063-116331332
   PubMed Web of Science ®Google Scholar
• Aubry-Damon H, Soussy CJ, Courvalin P. Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 1998;42:2590–2594. doi:10.1128/AAC.42.10.25909756760
   PubMed Web of Science ®Google Scholar
• Wichelhaus TA, Schafer V, Brade V, Boddinghaus B. Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1999;43:2813–2816. doi:10.1128/AAC.43.11.281310543773
   PubMed Web of Science ®Google Scholar
• Bankevich A, Nurk S, Antipov D, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19:455–477. doi:10.1089/cmb.2012.002122506599
   PubMed Web of Science ®Google Scholar
• Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30:2068–2069. doi:10.1093/bioinformatics/btu15324642063
   PubMed Web of Science ®Google Scholar
• Gajdacs M. The concept of an ideal antibiotic: implications for drug design. Molecules. 2019;24:892. doi:10.3390/molecules24050892
   PubMed Web of Science ®Google Scholar
• Song JH, Hsueh PR, Chung DR, et al. Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study. J Antimicrob Chemother. 2011;66:1061–1069. doi:10.1093/jac/dkr02421393157
   PubMed Web of Science ®Google Scholar
• Cheng H, Yuan W, Zeng F, et al. Molecular and phenotypic evidence for the spread of three major methicillin-resistant Staphylococcus aureus clones associated with two characteristic antimicrobial resistance profiles in China. J Antimicrob Chemother. 2013;68:2453–2457. doi:10.1093/jac/dkt21323766485
   PubMed Web of Science ®Google Scholar
• Chen H, Liu Y, Jiang X, Chen M, Wang H. Rapid change of methicillin-resistant Staphylococcus aureus clones in a Chinese tertiary care hospital over a 15-year period. Antimicrob Agents Chemother. 2010;54:1842–1847. doi:10.1128/AAC.01563-0920176895
   PubMed Web of Science ®Google Scholar
• Beukers AG, Newton P, Hudson B, et al. A multicentre outbreak of ST45 MRSA containing deletions in the spa gene in New South Wales, Australia. J Antimicrob Chemother. 2020;75:1112–1116. doi:10.1093/jac/dkz56032016400
   PubMed Web of Science ®Google Scholar
• Gao W, Cameron DR, Davies JK, et al. The rpoB H(4)(8)(1)Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus. J Infect Dis. 2013;207:929–939. doi:10.1093/infdis/jis77223255563
   PubMed Web of Science ®Google Scholar